Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 109

Results For "ABLE"

6979 News Found

Gujarat Themis Biosyn to acquire anti-TB and anti-infective brands from Sanofi for EUR 158 Million
News | April 24, 2026

Gujarat Themis Biosyn to acquire anti-TB and anti-infective brands from Sanofi for EUR 158 Million

Deal includes 13 branded generic products across 55+ countries; acquisition expected to strengthen global anti-infective portfolio and expand regulated market presence


Merck & Google Cloud ink $1 billion AI deal to build “Agentic” pharma future
Digitisation | April 24, 2026

Merck & Google Cloud ink $1 billion AI deal to build “Agentic” pharma future

The collaboration will roll out an “agentic” AI platform across Merck’s research & development, manufacturing, commercial, and corporate operations


Johnson & Johnson wins EU nod for next-gen surgical stapler
Medical Device | April 24, 2026

Johnson & Johnson wins EU nod for next-gen surgical stapler

The ETHICON 4000 Stapler and ETHICON 3D Reloads are now approved for use in both open and laparoscopic surgeries across the European Union


Philips bags FDA nod for next-gen CT platform
Medical Device | April 24, 2026

Philips bags FDA nod for next-gen CT platform

Aims to boost speed & precision in patient care


Cipla’s generic Ventolin HFA secures USFDA approval
Drug Approval | April 23, 2026

Cipla’s generic Ventolin HFA secures USFDA approval

Approval for Albuterol Sulfate inhalation aerosol enables Cipla Limited to enter the $1.5 billion U.S. albuterol market


Terumo India and AIG Hospitals partner to boost interventional radiology training and patient outcomes nationwide
Hospitals | April 23, 2026

Terumo India and AIG Hospitals partner to boost interventional radiology training and patient outcomes nationwide

The collaboration is designed to improve clinical outcomes, reduce procedural risks, and expand access to advanced image-guided treatments across a growing range of conditions


AbbVie bets $1.4B on North Carolina pharma mega-campus
News | April 23, 2026

AbbVie bets $1.4B on North Carolina pharma mega-campus

Once complete, the site will serve as AbbVie’s U.S. center of excellence for SVP manufacturing


Evonik bets €80 million on biotech expansion to power next-gen pharma growth
Biotech | April 23, 2026

Evonik bets €80 million on biotech expansion to power next-gen pharma growth

The investment will bring in cutting-edge downstream fermentation technology, strengthening the company’s contract manufacturing capabilities for drug substances


Medix Biochemica elevates Petra Furu to CEO role
People | April 23, 2026

Medix Biochemica elevates Petra Furu to CEO role

With a PhD in Biochemistry and an executive MBA, she brings nearly two decades of experience in the in vitro diagnostics (IVD) sector